We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Genetic Mystery of Behçet's Disease Revealed

By LabMedica International staff writers
Posted on 23 Jan 2013
Four new regions on the human genome that have been identified are associated with Behçet's disease, which causes inflammation of blood vessels in various parts of the body. More...


Behçet's disease is triggered by complex genetic and environmental factors and common symptoms include painful mouth and genital sores, and eye inflammation that can lead to blindness.

Scientists at the National Human Genome Research Institute (Bethesda, MD, USA) conducted a genome-wide association study (GWAS) that enrolled 1,209 Turkish people affected by Behçet's disease and 1,278 unaffected Turkish people, all of whom were indigenous residents of the country. The team looked at single-nucleotide polymorphisms (SNPs) on the human genome, with each SNP representing a difference in a single DNA building block and compared SNP differences between people with and without disease.

From nearly 800,000 SNPs, the investigators detected and mapped a small number that are found in those who have Behçet's disease at a significantly higher rate than in those without the disease, suggesting that the variant or another one nearby contributes to the disease. As not all the SNPs were genotyped, the team used the strategy of imputing, or surmising, that there were genotypes worth investigating near known variants.

An important association was found between Behçet's disease and a gene called endoplasmic reticulum aminopeptidase 1 (ERAP1) which codes for a molecule that processes microbial proteins in white blood cells. A significant association of Behçet's disease with variants near the chemokine (C-C motif) receptor 1 (CCR1) gene was also noted. Proteins coded by this gene help infection-fighting blood cells migrate to sites of invading microorganisms. An association of the disease was found with variants in the killer cell lectin-like receptor subfamily C, member 4 (KLRC4) gene and the signal transducer and activator of transcription 4 (STAT4) gene, in which different variants in the same vicinity of the genome increase risk for autoimmune diseases, including rheumatoid arthritis and lupus.

The four newly identified gene regions were already known to play a role in immune regulation. The genetic associations have helped classify Behçet's disease with more common inflammatory conditions such as psoriasis, inflammatory bowel disease, and a form of spinal arthritis called ankylosing spondylitis. Elaine F. Remmers, PhD, a coauthor of the study said, "Each of the genetic factors may contribute a little to the overall risk of disease. We are also identifying them in pathways that are important in inflammatory disease development." The study was published on January 6, 2013, in the journal Nature Genetics.

Related Links:

[US] National Human Genome Research Institute




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.